The enthusiasm for India and China may be diminishing, writes Eric Langer.
Preliminary results from BioPlan Associates' 9th Annual Report and Survey of Biomanufacturing suggest there's a good reason to be optimistic about 2012.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva